Skip to main content

Advantmed Appoints Dr. Matt Lambert as Chief Medical Officer and Head of Product Strategy

Advantmed, LLC, an industry leader in risk adjustment and quality services for health plans and providers, today announced the appointment of Dr. Matt Lambert as Chief Medical Officer and Head of Product Strategy. Dr. Lambert brings more than two decades of clinical experience and extensive executive leadership in healthcare technology, product innovation, and value-based care strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303323037/en/

Dr. Matt Lambert, Chief Medical Officer and Head of Product Strategy, Advantmed

Dr. Matt Lambert, Chief Medical Officer and Head of Product Strategy, Advantmed

Dr. Lambert joins Advantmed at a pivotal time as health plans and providers navigate continued regulatory change and increasing complexity across risk adjustment and quality programs. In his new role, he will lead clinical strategy and product development efforts to strengthen Advantmed’s integrated solution offerings, with an immediate focus on enhancing the company’s In-Home Assessment (IHA) program.

“We are excited to welcome Dr. Lambert to Advantmed’s executive leadership team,” said Akash Patel, Co-Founder and CEO of Advantmed. “His clinical background combined with his deep expertise in healthcare and product strategy will play a critical role as we continue expanding our capabilities and delivering innovative solutions that help our clients succeed in a rapidly evolving market.”

Dr. Lambert will prioritize advancing Advantmed’s In-Home Assessment program to further improve member engagement, reconnect individuals to primary care, and support the closure of chronic condition and quality gaps. He will also lead enhancements to the company’s pre-visit clinical review processes and supporting technology infrastructure to drive greater efficiency, accuracy, and scalability.

“In-home assessments provide a meaningful opportunity to engage members while strengthening risk and quality performance,” said Dr. Lambert. “Advantmed has built a strong foundation in operational excellence, and I look forward to building on that success by enhancing our product strategy and leveraging technology to deliver even greater value to our clients.”

Dr. Lambert brings a strong record of leadership across healthcare organizations focused on innovation and performance improvement. He previously served as Chief Medical Officer for Curation Health, which was later acquired by Reveleer; Chief Medical Officer for HealthNXt, a Tech Mahindra company; and CMO for Socially Determined. His prior roles also include Director of Emerging Technology at NEOM, Physician Program Director for Epic at the University of Washington, Chief Medical Information Officer for New York City Health and Hospitals, and CMIO for Clinovations, which was acquired by the Advisory Board.

Throughout his career, Dr. Lambert has focused on leveraging healthcare technology to improve population health initiatives, strengthen risk and quality performance, reduce clinician burden, and support cost-effective care delivery.

Dr. Lambert did his undergraduate studies in Chemistry at Marshall University and his M.D. from the Joan C. Edwards School of Medicine at Marshall University. He completed his residency training in Emergency Medicine at West Virginia University School of Medicine.

About Advantmed:

Founded in 2005, Advantmed is the industry-leading provider of medical record retrieval, medical record review and health assessment solutions for health plans and providers. Through a tailored, cost-effective suite of services addressing risk adjustment and quality needs, Advantmed seeks to improve healthcare outcomes and performance across the organizations it serves.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.54
-3.85 (-1.85%)
AAPL  262.88
-1.85 (-0.70%)
AMD  191.48
-7.14 (-3.59%)
BAC  48.66
-1.16 (-2.32%)
GOOG  299.88
-6.48 (-2.12%)
META  646.63
-6.93 (-1.06%)
MSFT  394.96
-3.59 (-0.90%)
NVDA  179.09
-3.39 (-1.86%)
ORCL  144.48
-4.77 (-3.20%)
TSLA  392.15
-11.17 (-2.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.